Vertex Pharmaceuticals Inc, a pioneer in the field of cystic fibrosis, has turned to gene editing technology to help it advance its portfolio of drugs that target gene-based diseases. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
